Screening for Lung Cancer

Lung cancer screening can find cancer early and save your life. Find out what it is, why it’s important, if you are eligible, and next steps.

Learn About Your Risk

From risk factors to how lung cancer develops, this section will provide you with a greater understanding of how and why lung cancer can develop.

Early Lung Cancer Screening

Who should be screened? How is screening done? Get the facts here, plus take the quiz to determine whether you are a candidate for lung cancer screening.

Understanding Your Results

Once your screening results are in, then what? In this section, you’ll learn about what the results may mean and how to take any next steps to care for yourself.

Latest News & Blogs

Take Action! Tell Your Senators What Lung Cancer Research Means to You

The lung cancer community has a unique and urgent opportunity to influence the future of lung cancer research funding in Congress. The Lung Cancer Research Program (LCRP), part of the Congressionally Directed Medical Research Program (CDMRP) within the Department of Defense, is an important source

LUNGevity Launches New EGFR Patient Gateway

WASHINGTON, DC (May 4, 2022) — LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit organization, has launched the EGFR Lung Cancer Patient Gateway.

Cancer Disclosure in the Workplace

It can be difficult to decide what information to disclose at your workplace when navigating a cancer diagnosis. You may question whether or not to share your diagnosis with coworkers, what information you’ll be required to tell your employer, and how to receive workplace benefits such as time off

The Power of Mindset

April is Stress Awareness Month, and for those living with lung cancer, feelings of stress or anxiety can become unwelcome symptoms of the changes and challenges living with lung cancer creates. However, tools like mindset and mindfulness have led to individuals gaining a sense of control over

LUNGevity Names Maisha Standifer, PhD, MPH, LUNGevity Community Scholar-in-Residence

WASHINGTON, DC (April 27, 2022) — LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit organization, welcomes Maisha Standifer, PhD, MPH, as its first Community Scholar-in-Residence. In this new position, Dr.

Highlights of the 2022 AACR meeting

The American Association for Cancer Research (AACR) 2022 meeting was held in New Orleans from April 9 to 13. Doctors and researchers worldwide joined together virtually and in person to make this year’s meeting one of the largest gatherings since the start of the pandemic. They shared the many

KRAS: How It Started vs. How It’s Going

On May 28, 2021, the United States Food & Drug Administration (FDA) approved sotorasib as the first targeted therapy for patients with KRAS G12C-positive non-small cell lung cancer (NSCLC). Both researchers and patients celebrated this historic breakthrough, which had been a goal since

National Volunteer Week – Meet LUNGevity’s Volunteers

At LUNGevity, we say that our people are our most valuable asset, and our dedicated volunteers exemplify this. Hundreds of volunteers from across the country support LUNGevity and the community we serve. Volunteers use their unique talents and perspectives to provide peer support, raise awareness

Understanding Lung Cancer Stages

For people with lung cancer, one of the first steps in navigating their diagnosis comes from understanding what their lung cancer stage means for the future of their treatment. After someone is diagnosed with lung cancer, health care providers go through a process called “staging.” A “stage” is

Brandon Leonard, MA, Joins LUNGevity as Director of Government Affairs

WASHINGTON, DC (April 11, 2022) — LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit organization, welcomes Brandon Leonard, MA, as its Director of Government Affairs.

Brendon Stiles, MD, Joins LUNGevity Scientific Advisory Board

WASHINGTON (April 7, 2022) — LUNGevity Foundation extends its welcome to the foundation’s newest Scientific Advisory Board member, Brendon Stiles, MD. Dr.

Angela James, MBA, LMSW, MEd, Joins LUNGevity as Care Navigator

WASHINGTON, DC (March 29, 2022) — LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit organization, welcomes Angela James, MBA, LMSW, MEd, as its Care Navigator.

Support Our Work

Your support will help drive advances in lung cancer detection and treatment that are saving lives, and provide free education and support to all affected by lung cancer. Make a tax-deductible donation now, or fundraise with LUNGevity!

DONATE NOW